BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31042586)

  • 1. A mutual activation loop between the Ca
    Wang H; Yao F; Luo S; Ma K; Liu M; Bai L; Chen S; Song C; Wang T; Du Q; Wu H; Wei M; Fang Y; Xiao Q
    Cancer Lett; 2019 Jul; 455():48-59. PubMed ID: 31042586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
    Kulkarni S; Bill A; Godse NR; Khan NI; Kass JI; Steehler K; Kemp C; Davis K; Bertrand CA; Vyas AR; Holt DE; Grandis JR; Gaither LA; Duvvuri U
    Genes Chromosomes Cancer; 2017 Jun; 56(6):460-471. PubMed ID: 28177558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-specific mechanisms of TMEM16A Ca
    Wang H; Zou L; Ma K; Yu J; Wu H; Wei M; Xiao Q
    Mol Cancer; 2017 Sep; 16(1):152. PubMed ID: 28893247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
    Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis.
    Crottès D; Lin YT; Peters CJ; Gilchrist JM; Wiita AP; Jan YN; Jan LY
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13026-13035. PubMed ID: 31182586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMEM16A as a Potential Biomarker in the Diagnosis and Prognosis of Lung Cancer.
    Hu C; Zhang R; Jiang D
    Arch Iran Med; 2019 Jan; 22(1):32-38. PubMed ID: 30821158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of TMEM16A Ca
    Luo S; Wang H; Bai L; Chen Y; Chen S; Gao K; Wang H; Wu S; Song H; Ma K; Liu M; Yao F; Fang Y; Xiao Q
    J Adv Res; 2021 Nov; 33():253-264. PubMed ID: 34603794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment.
    Wu H; Guan S; Sun M; Yu Z; Zhao L; He M; Zhao H; Yao W; Wang E; Jin F; Xiao Q; Wei M
    PLoS One; 2015; 10(5):e0126128. PubMed ID: 25961581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Ca
    Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
    Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.
    Balanis N; Wendt MK; Schiemann BJ; Wang Z; Schiemann WP; Carlin CR
    J Biol Chem; 2013 Jun; 288(25):17954-67. PubMed ID: 23653350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 mediated upregulation of C-MET signaling acts as a compensatory survival mechanism upon EGFR family inhibition in chemoresistant breast cancer cells.
    Zhu Y; Zhang H; Han X; Wang Z; Cui Y; Tian R; Wang Z; Han B; Tian J; Zhang F; Niu R
    Cancer Lett; 2021 Oct; 519():328-342. PubMed ID: 34348188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of TMEM16A by CK2 and Its Role in Cellular Proliferation.
    Pinto MC; Schreiber R; Lerias J; Ousingsawat J; Duarte A; Amaral M; Kunzelmann K
    Cells; 2020 May; 9(5):. PubMed ID: 32380794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
    Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
    Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM16A Ca
    Wang Q; Bai L; Luo S; Wang T; Yang F; Xia J; Wang H; Ma K; Liu M; Wu S; Wang H; Guo S; Sun X; Xiao Q
    J Adv Res; 2020 May; 23():25-35. PubMed ID: 32071789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
    Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA
    Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis.
    Mapes J; Anandan L; Li Q; Neff A; Clevenger CV; Bagchi IC; Bagchi MK
    J Biol Chem; 2018 Feb; 293(8):2850-2864. PubMed ID: 29321207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits oral squamous cell carcinoma by targeting TMEM16A Ca
    Wang H; Wang T; Zhang Z; Fan Y; Zhang L; Gao K; Luo S; Xiao Q; Sun C
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1699-1711. PubMed ID: 33755783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling.
    Song Y; Gao J; Guan L; Chen X; Gao J; Wang K
    Cell Death Dis; 2018 Jun; 9(6):703. PubMed ID: 29899325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TINCR favors tumorigenesis via STAT3-TINCR-EGFR-feedback loop by recruiting DNMT1 and acting as a competing endogenous RNA in human breast cancer.
    Wang Q; Liu J; You Z; Yin Y; Liu L; Kang Y; Li S; Ning S; Li H; Gong Y; Xu S; Pang D
    Cell Death Dis; 2021 Jan; 12(1):83. PubMed ID: 33446634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth
    Zeng X; Qu X; Zhao C; Xu L; Hou K; Liu Y; Zhang N; Feng J; Shi S; Zhang L; Xiao J; Guo Z; Teng Y; Che X
    FASEB J; 2019 Oct; 33(10):10717-10730. PubMed ID: 31266372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.